BackPhoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War) Overview
Phoenix Biotech Acquisition Corp - Units (1 Ord Class A & 1/2 War)

Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War) PEG Ratio

Valuation check: PBAXU's PEG ratio is -3.26, above the sector sector average of -7.59.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

-3.26

PEG Ratio

-3.26

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

Average PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War) (PBAXU) FAQ

The latest PEG ratio for PBAXU is -3.26. That is above the sector sector average of -7.59. Investors often review this figure alongside Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War)'s historical trend and sector peers before judging valuation or financial health.

Against its sector companies, PBAXU currently prints -3.26 for PEG ratio, while the sector average sits near -7.59. That is roughly 57.1% above the sector mean. Large gaps often invite a closer look at Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War)'s growth, margins, and balance sheet.

A PEG ratio of -3.26 for Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War) is not 'good' or 'bad' on its own. Compare it with the peer average (-7.59) and with PBAXU's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting PBAXU's PEG ratio (-3.26), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.